日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Developing and Testing a User-Focused, Web GIS-Based Food Asset Map for an Under-Resourced Community in Northeastern Connecticut

为康涅狄格州东北部资源匮乏社区开发和测试以用户为中心的基于网络地理信息系统的食品资产地图

Chen, Xiran; Mofrad, Manije Darooghegi; Clements, Sydney; Killion, Kate; Johnson, Thess; Chen, Xiang; Zigmont, Donna; Avelino, Daniela C; Lituma-Solis, Brenda; Puglisi, Michael J; Duffy, Valerie B; Chun, Ock K

Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses

优化的 mRNA 非编码区 SARS-CoV-2 疫苗 CV2CoV 可改善同源和异源中和抗体反应

Nicole Roth, Jacob Schön, Donata Hoffmann, Moritz Thran, Andreas Thess, Stefan O Mueller, Benjamin Petsch, Susanne Rauch

Development and operationalization of disaster risk management framework for COVID-19 pandemic: Quezon City inclusive unified response, recovery, and rehabilitation action plan 2020–2030

制定和实施新冠肺炎疫情灾害风险管理框架:奎松市包容性统一应对、恢复和重建行动计划(2020-2030 年)

Maxwell, Keely; Raza, Tabassam; Marasigan, Karl Michael; Raza, Thess Khaz; Villodres, Arvin Fuma-ob; Perez, Bianca; Macalalad, Jade; Belmonte, Josefina; Alimurung, Michael

CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2

CVnCoV 和 CV2CoV 可保护人类 ACE2 转基因小鼠免受祖先 B BavPat1 和新出现的 B.1.351 SARS-CoV-2 的感染。

Hoffmann, Donata; Corleis, Björn; Rauch, Susanne; Roth, Nicole; Mühe, Janine; Halwe, Nico Joel; Ulrich, Lorenz; Fricke, Charlie; Schön, Jacob; Kraft, Anna; Breithaupt, Angele; Wernike, Kerstin; Michelitsch, Anna; Sick, Franziska; Wylezich, Claudia; Hoffmann, Bernd; Thran, Moritz; Thess, Andreas; Mueller, Stefan O; Mettenleiter, Thomas C; Petsch, Benjamin; Dorhoi, Anca; Beer, Martin

mRNA as novel technology for passive immunotherapy

mRNA作为一种新型被动免疫疗法技术

Schlake, Thomas; Thess, Andreas; Thran, Moritz; Jordan, Ingo

mRNA mediates passive vaccination against infectious agents, toxins, and tumors

mRNA介导针对传染性病原体、毒素和肿瘤的被动免疫。

Moritz Thran ,Jean Mukherjee ,Marion Pönisch ,Katja Fiedler ,Andreas Thess ,Barbara L Mui ,Michael J Hope ,Ying K Tam ,Nigel Horscroft ,Regina Heidenreich ,Mariola Fotin-Mleczek ,Charles B Shoemaker ,Thomas Schlake

Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals

无需化学核苷修饰的序列工程 mRNA 可对大型动物进行有效的蛋白质治疗

Andreas Thess, Stefanie Grund, Barbara L Mui, Michael J Hope, Patrick Baumhof, Mariola Fotin-Mleczek, Thomas Schlake

A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines

一种新型的、颠覆性的疫苗技术:自佐剂RNActive®疫苗

Kallen, Karl-Josef; Heidenreich, Regina; Schnee, Margit; Petsch, Benjamin; Schlake, Thomas; Thess, Andreas; Baumhof, Patrick; Scheel, Birgit; Koch, Sven D; Fotin-Mleczek, Mariola

Developing mRNA-vaccine technologies

开发mRNA疫苗技术

Schlake, Thomas; Thess, Andreas; Fotin-Mleczek, Mariola; Kallen, Karl-Josef

Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer

针对 RAI3 及其在人乳腺癌中表达的单克隆抗体的制备和表征

Jörissen, Hannah; Bektas, Nuran; Dahl, Edgar; Hartmann, Arndt; ten Haaf, Anette; Di Fiore, Stefano; Kiefer, Hans; Thess, Andreas; Barth, Stefan; Klockenbring, Torsten